Literature DB >> 15024143

Refractory polymyositis responding to infliximab: extended follow-up.

I Labioche, E Liozon, B Weschler, V Loustaud-Ratti, P Soria, E Vidal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15024143     DOI： 10.1093/rheumatology/keh079

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  19 in total

1.  Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 2.  Skeletal muscle disorders associated with inflammatory bowel diseases: occurrence of myositis in a patient with ulcerative colitis and Hashimoto's thyroiditis--case report and review of the literature.

Authors:  Omero Alessandro Paoluzi; Pietro Crispino; Margherita Rivera; Federico Iacopini; Dino Palladini; Adriana Consolazio; Paolo Paoluzi
Journal:  Int J Colorectal Dis       Date:  2005-10-05       Impact factor: 2.571

3.  Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature.

Authors:  Paola Caramaschi; Alessandro Volpe; Antonio Carletto; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2007-01-17       Impact factor: 2.980

4.  Idiopathic inflammatory myopathy: treatment options.

Authors:  Stephen J DiMartino
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

Review 5.  Immunotherapy of myositis: issues, concerns and future prospects.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Rheumatol       Date:  2010-02-02       Impact factor: 20.543

6.  Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.

Authors:  Yuki Ishikawa; Naoichiro Yukawa; Koichiro Ohmura; Yuji Hosono; Yoshitaka Imura; Daisuke Kawabata; Takaki Nojima; Takao Fujii; Takashi Usui; Tsuneyo Mimori
Journal:  Clin Rheumatol       Date:  2010-02-09       Impact factor: 2.980

7.  Immunotherapy of inflammatory myopathies: practical approach and future prospects.

Authors:  Marinos C Dalakas
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

Review 8.  Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies.

Authors:  Namita A Goyal; Tahseen Mozaffar
Journal:  Curr Treat Options Neurol       Date:  2018-07-23       Impact factor: 3.598

Review 9.  The utility of tumour necrosis factor blockade in orphan diseases.

Authors:  E C Keystone
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 10.  Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

Authors:  E M Moran; F L Mastaglia
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.